help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH


This item requires a subscription to The Oncologist Online.
Cover Full Text
FDA Review of a Panitumumab (VectibixTM) Clinical Trial for First-Line Treatment...
Giusti et al. Oncologist.2009; 14: 284-290
To view this item, select one of the options below:
* Sign In
* Sign in without cookies.

* Can't get past this page?

* Help with Cookies.

* Need to Activate?
Forgot your user name or password?
* Sign Up
* Subscribe to the Journal - Subscribe to the print and/or online journal.
* Renew Online - Renew your subscription online. [regain access to your recent online renewal]
* Member Subscribers
* Become a Charter Member of the Society for Translational Oncology (STO) and receive unlimited access to The Oncologist as a member benefit for $125 through 2010, including access to 20 CME courses at no additional cost.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giusti, R. M.
Right arrow Articles by Pazdur, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giusti, R. M.
Right arrow Articles by Pazdur, R.

HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2009 by AlphaMed Press.